Skip to main content
NIH funding notice RFA-ES-14-005

Novel Technologies for Rapid and Sensitive Biomonitoring in Humans (R43/R44)

Closed on August 15, 2014.

Posted
May 9, 2014
Close date
August 15, 2014
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,199,993 in first-year total cost, median $225,000.

Most frequent study sections

  1. Special Emphasis Panel[ZES1 SET-J (R4)]3

Most frequent institutions

  1. CHROMOLOGIC, LLC1
  2. NEWOMICS, INC1
  3. VAXESS TECHNOLOGIES, INC.1
Competing awards under RFA-ES-14-005 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2015Microfluidic Chips for Biomonitoring2R44ES022360-02WANG, DAOJINGNEWOMICS, INC, CA$750,000ZES1
2015Silk-based biospecimen stabilization for exposure assessment diagnostics1R43ES025516-01KLUGE, JONATHAN AUGUSTVAXESS TECHNOLOGIES, INC., MA$225,000ZES1
2015Rapid Biomonitoring of Volatile Toxins in Human Samples (BIO-VOTO)1R43ES025526-01LUE, LORMENCHROMOLOGIC, LLC, CA$224,993ZES1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-ES-14-005: Novel Technologies for Rapid and Sensitive Biomonitoring in Humans (R43/R44) | ScienceDex | ConductScience